ESLA
NASD Estrella Immunopharma, Inc.$0.4100 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.4100, $0.0326 below the day’s high of $0.4426
- YTD change
- -73.72%
- vs 20-day SMA
- -18.16%
- vs 200-day SMA
- -60.99%
Price ranges
Price & Performance
-1.43 (-77.72%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 92.7% away from all-time highs of $5.6200
- ESLA is down 74% since the beginning of the year
- ESLA is down 67% over the past 12 months
- ESLA is down 39% over the past 1 month
- 1% of all ESLA investors are betting against ESLA
ESLA reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -68.2%.
- Previous minute
- +$0.0000
- Last hour
- -$0.0099
- Last 5 days
- -13.68%
- vs 8-day SMA
- -8.27%
No alerts for ESLA in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.
Competitor comparison
No peer group available for this symbol.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.